AI 유전체학 시장 규모, 점유율 및 동향 분석 보고서 : 컴포넌트별, 기술별, 기능별, 용도별, 최종 용도별, 지역별, 부문 예측(2026-2033년)
AI In Genomics Market Size, Share & Trends Analysis Report By Component (Hardware, Software), By Technology (Machine Learning), By Functionality (Genome Sequencing, Gene Editing), By Application, By End Use, By Region, And Segment Forecasts 2026 - 2033
상품코드:1941475
리서치사:Grand View Research
발행일:2026년 01월
페이지 정보:영문 100 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
유전체학 AI 시장 개요
세계의 유전체학 AI 시장 규모는 2025년에 12억 6,000만 달러로 평가되었고 2033년에 188억 2,000만 달러에 이를 것으로 예측됩니다.
또한 2026-2033년에는 CAGR 40.30%를 나타낼 것으로 예측됩니다. 유전체 데이터 양 증가, 정밀의료에 대한 수요 증가, 신약 개발 및 개발 가속화가 시장 성장의 주요 요인으로 작용하고 있습니다.
기술 발전과 산업 연계가 시장 환경을 강화하고 있습니다. 차세대 시퀀싱 기술의 급속한 발전으로 유전체 데이터 세트의 양과 복잡성이 크게 증가했습니다. 전장유전체 분석이나 멀티오믹스 연구에서는 기존 바이오인포매틱스 툴의 처리 능력을 넘어서는 데이터가 생성됩니다. 예를 들어, 미국 국립인간유전체연구소는 향후 10년간 유전체 연구를 통해 2-40 엑사바이트의 데이터가 생성될 것으로 예측했습니다. 그러나 AI는 이러한 대규모 데이터 세트의 확장 가능한 처리, 해석 및 통합을 가능하게 합니다. 데이터 양의 급증으로 유전체 연구와 임상 적용에 있어 AI는 필수 불가결한 요소로 자리 잡았습니다. 이러한 구조적 변화가 유전체학 분야의 AI 도입을 강력하게 추진하고 있습니다.
정밀의료에 대한 수요 증가는 시장 성장을 더욱 촉진하고 있습니다. 유전체 분석의 결과는 환자별 질병 위험도를 파악하고 치료 반응을 예측하는 데 필수적입니다. AI는 복잡한 유전자형과 표현형의 관계를 대규모로 해석하는 데 도움을 줍니다. 정밀 종양학, 희귀질환 진단, 약리유전체학은 AI를 활용한 유전체학에 대한 의존도가 높아지고 있습니다. 또한, 임상 데이터와의 통합을 통해 실질적인 의사결정을 개선할 수 있습니다. 예를 들어, 2025년 11월 AMP 연례총회에서 컴플리트 지노믹스와 SOPHiA GENETICS는 SOPHiA DDM이 탑재된 IMSK-IMPACT와 MSK-Access를 DNBSEQ-T1+ 시퀀서에 통합하여 엔드투엔드 AI 기반 암 유전체 프로파일링을 실현하였습니다.
목차
제1장 조사 방법과 범위
제2장 주요 요약
제3장 유전체학 AI 시장 변수, 동향과 범위
제4장 유전체학 AI 시장 I : 컴포넌트별, 추정·동향 분석
제5장 유전체학 AI 시장 : 기술별, 추정·동향 분석
제6장 유전체학 AI 시장 : 기능별, 추정·동향 분석
제7장 유전체학 AI 시장 : 용도별, 추정·동향 분석
제8장 유전체학 AI 시장 : 최종 용도별, 추정·동향 분석
제9장 유전체학 AI 시장 : 지역별, 추정·동향 분석
제10장 경쟁 구도
LSH
영문 목차
영문목차
AI In Genomics Market Summary
The global AI in genomics market size was valued at USD 1.26 billion in 2025 and is projected to reach USD 18.82 billion by 2033, growing at a CAGR of 40.30% from 2026 to 2033. The growing volume of genomic data, the rising demand for precision medicine, and the acceleration of drug discovery & development are significant factors contributing to market growth.
Moreover, technological advancements and industry partnerships are strengthening the market environment. Rapid advances in next-generation sequencing have significantly increased the volume and complexity of genomic datasets. Whole-genome and multi-omics studies generate data that exceed the capacity of traditional bioinformatics tools. For instance, the National Human Genome Research Institute predicts that genomics research is expected to generate between 2 and 40 exabytes of data within the next decade. However, AI enables scalable processing, interpretation, and integration of these large datasets. The growing intensity of data makes AI essential for genomic research and clinical applications. This structural shift strongly drives AI adoption in genomics.
Moreover, the increasing demand for precision medicine further drives market growth. Genomic insights are crucial for identifying patient-specific disease risks and predicting therapy responses. AI supports the interpretation of complex genotype-phenotype relationships at scale. Precision oncology, rare disease diagnostics, and pharmacogenomics increasingly rely on AI-enabled genomics. In addition, integration with clinical data improves actionable decision-making. For instance, in November 2025, Complete Genomics and SOPHiA GENETICS collaborated at the AMP Annual Meeting to integrate IMSK-IMPACT and MSK-ACCESS, powered by SOPHiA DDM, onto the DNBSEQ-T1+ sequencer, delivering end-to-end, AI-driven cancer genomic profiling.
Global AI in Genomics Market Report Segmentation
This report forecasts, revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented global AI in genomics market report based on component, technology, functionality, application, end use, and region.
Component Outlook (Revenue, USD Million, 2021 - 2033)
Software
Hardware
Service
Technology Outlook (Revenue, USD Million, 2021 - 2033)
Machine Learning (ML)
Deep Learning
Supervised Learning
Unsupervised Learning
Others
Computer Vision
Functionality Outlook (Revenue, USD Million, 2021 - 2033)
Genome Sequencing
Gene Editing
Others
Application Outlook (Revenue, USD Million, 2021 - 2033)
Drug Discovery & Development
Precision Medicine
Diagnostics
Other Applications
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Pharmaceutical and Biotech Companies
Healthcare Providers
Research Centers
Others
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
MEA
South Africa
Saudi Arabia
UAE
Kuwait
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Component Segment
1.2.2. Technology Segment
1.2.3. Functionality Segment
1.2.4. Application Segment
1.2.5. End Use
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. AI in Genomics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.2.3. Market opportunity analysis
3.2.4. Market challenges analysis
3.3. AI in Genomics Market Analysis Tools
3.3.1. Industry Analysis - Porter's
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.2.4. Environmental Landscape
3.3.2.5. Legal Landscape
3.3.2.6. Social Landscape
Chapter 4. AI in Genomics Market: Component Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global AI in Genomics Market Component Movement Analysis
4.3. Global AI in Genomics Market Size & Trend Analysis, by Component, 2021 to 2033 (USD Million)
4.4. Software
4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
4.5. Hardware
4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
4.6. Services
4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 5. AI in Genomics Market: Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global AI in Genomics Market Technology Movement Analysis
5.3. Global AI in Genomics Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
5.4. Machine Learning Algorithms
5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
5.4.2. Deep learning
5.4.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
5.4.3. Supervised
5.4.3.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
5.4.4. Unsupervised
5.4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
5.4.5. Others
5.4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
5.5. Computer Vision
5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 6. AI in Genomics Market: Functionality Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global AI in Genomics Market Functionality Movement Analysis
6.3. Global AI in Genomics Market Size & Trend Analysis, by Functionality, 2021 to 2033 (USD Million)
6.4. Genome Sequencing
6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
6.5. Gene Editing
6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
6.5.2. Others
6.5.3. Market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 7. AI in Genomics Market: Application Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global AI in Genomics Market Application Movement Analysis
7.3. Global AI in Genomics Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
7.4. Drug Discovery & Development
7.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
7.5. Precision Medicine
7.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
7.6. Diagnostics
7.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
7.7. Other Applications
7.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 8. AI in Genomics Market: End Use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Global AI in Genomics Market End Use Movement Analysis
8.3. Global AI in Genomics Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
8.4. Pharmaceutical and Biotech Companies
8.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
8.5. Healthcare Providers
8.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
8.6. Research Centers
8.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
8.7. Others
8.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 9. AI in Genomics Market: Regional Estimates & Trend Analysis
9.1. Regional Market Share Analysis, 2025 & 2033
9.2. Regional Market Dashboard
9.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
9.4. North America
9.4.1. U.S.
9.4.1.1. Key country dynamics
9.4.1.2. Regulatory framework
9.4.1.3. Competitive scenario
9.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
9.4.2. Canada
9.4.2.1. Key country dynamics
9.4.2.2. Regulatory framework
9.4.2.3. Competitive scenario
9.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
9.4.3. Mexico
9.4.3.1. Key country dynamics
9.4.3.2. Regulatory framework
9.4.3.3. Competitive scenario
9.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
9.5. Europe
9.5.1. UK
9.5.1.1. Key country dynamics
9.5.1.2. Regulatory framework
9.5.1.3. Competitive scenario
9.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
9.5.2. Germany
9.5.2.1. Key country dynamics
9.5.2.2. Regulatory framework
9.5.2.3. Competitive scenario
9.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
9.5.3. France
9.5.3.1. Key country dynamics
9.5.3.2. Regulatory framework
9.5.3.3. Competitive scenario
9.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
9.5.4. Italy
9.5.4.1. Key country dynamics
9.5.4.2. Regulatory framework
9.5.4.3. Competitive scenario
9.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
9.5.5. Spain
9.5.5.1. Key country dynamics
9.5.5.2. Regulatory framework
9.5.5.3. Competitive scenario
9.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
9.5.6. Norway
9.5.6.1. Key country dynamics
9.5.6.2. Regulatory framework
9.5.6.3. Competitive scenario
9.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
9.5.7. Sweden
9.5.7.1. Key country dynamics
9.5.7.2. Regulatory framework
9.5.7.3. Competitive scenario
9.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
9.5.8. Denmark
9.5.8.1. Key country dynamics
9.5.8.2. Regulatory framework
9.5.8.3. Competitive scenario
9.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
9.6. Asia Pacific
9.6.1. Japan
9.6.1.1. Key country dynamics
9.6.1.2. Regulatory framework
9.6.1.3. Competitive scenario
9.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
9.6.2. China
9.6.2.1. Key country dynamics
9.6.2.2. Regulatory framework
9.6.2.3. Competitive scenario
9.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
9.6.3. India
9.6.3.1. Key country dynamics
9.6.3.2. Regulatory framework
9.6.3.3. Competitive scenario
9.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
9.6.4. Australia
9.6.4.1. Key country dynamics
9.6.4.2. Regulatory framework
9.6.4.3. Competitive scenario
9.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
9.6.5. South Korea
9.6.5.1. Key country dynamics
9.6.5.2. Regulatory framework
9.6.5.3. Competitive scenario
9.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
9.6.6. Thailand
9.6.6.1. Key country dynamics
9.6.6.2. Regulatory framework
9.6.6.3. Competitive scenario
9.6.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
9.7. Latin America
9.7.1. Brazil
9.7.1.1. Key country dynamics
9.7.1.2. Regulatory framework
9.7.1.3. Competitive scenario
9.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
9.7.2. Argentina
9.7.2.1. Key country dynamics
9.7.2.2. Regulatory framework
9.7.2.3. Competitive scenario
9.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
9.8. MEA
9.8.1. South Africa
9.8.1.1. Key country dynamics
9.8.1.2. Regulatory framework
9.8.1.3. Competitive scenario
9.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
9.8.2. Saudi Arabia
9.8.2.1. Key country dynamics
9.8.2.2. Regulatory framework
9.8.2.3. Competitive scenario
9.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
9.8.3. UAE
9.8.3.1. Key country dynamics
9.8.3.2. Regulatory framework
9.8.3.3. Competitive scenario
9.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
9.8.4. Kuwait
9.8.4.1. Key country dynamics
9.8.4.2. Regulatory framework
9.8.4.3. Competitive scenario
9.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)
